Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Systematic review of oxytocin dosing at caesarean section.

Stephens LC, Bruessel T.

Anaesth Intensive Care. 2012 Mar;40(2):247-52. Review.

2.

Pure ethiodized oil-based transcatheter ablative therapy in normal rabbit kidneys and kidneys inoculated with VX-2 carcinoma.

Kónya A, Stephens LC, Wright KC.

Cardiovasc Intervent Radiol. 2011 Oct;34(5):1031-41. doi: 10.1007/s00270-010-0014-9. Epub 2011 Jan 20.

PMID:
21249497
3.

Pure ethiodized oil as a capillary embolic agent with and without ethanol-ethiodol mixture in the rabbit kidney: embolic efficacy and temporal histopathologic findings.

Kónya A, Stephens LC, Wright KC.

J Vasc Interv Radiol. 2010 Jul;21(7):1091-9. doi: 10.1016/j.jvir.2010.02.037. Epub 2010 May 31.

PMID:
20570179
4.

Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Mills GB.

Cancer Cell. 2009 Jun 2;15(6):539-50. doi: 10.1016/j.ccr.2009.03.027. Erratum in: Cancer Cell. 2009 Aug 4;16(2):172.

5.

A pilot trial of vascular targeted photodynamic therapy for renal tissue.

Matin SF, Tinkey PT, Borne AT, Stephens LC, Sherz A, Swanson DA.

J Urol. 2008 Jul;180(1):338-42. doi: 10.1016/j.juro.2008.02.042. Epub 2008 May 22.

6.

Homozygous deletion of glycogen synthase kinase 3beta bypasses senescence allowing Ras transformation of primary murine fibroblasts.

Liu S, Fang X, Hall H, Yu S, Smith D, Lu Z, Fang D, Liu J, Stephens LC, Woodgett JR, Mills GB.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5248-53. doi: 10.1073/pnas.0704242105. Epub 2008 Mar 26.

7.

Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model.

Shetty AM, Stafford RJ, Elliott AM, Kassouf W, Brown GA, Stephens LC, Tinkey PT, Bidaut L, Pisters LL, Hazle JD.

J Magn Reson Imaging. 2007 Dec;26(6):1672-7.

PMID:
17968888
8.

Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.

Bagheri-Yarmand R, Balasenthil S, Gururaj AE, Talukder AH, Wang YH, Lee JH, Kim YS, Zhang X, Jones DM, Medeiros LJ, Stephens LC, Liu YJ, Lee N, Kim I, Kumar R.

Cancer Res. 2007 Aug 1;67(15):7062-7. Erratum in: Cancer Res. 2015 Jun 15;75(12):2582-3.

9.

Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.

Melancon MP, Wang Y, Wen X, Bankson JA, Stephens LC, Jasser S, Gelovani JG, Myers JN, Li C.

Invest Radiol. 2007 Aug;42(8):569-78.

10.

Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices.

Ahrar K, Stafford RJ, Tinkey PT, Borne AT, Stephens LC, Wallace MJ, Wright KC.

J Vasc Interv Radiol. 2007 Jul;18(7):929-35.

PMID:
17609457
11.

The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, Schober W, McQueen T, Dietrich M, Madden TL, Andreeff M.

Cancer Res. 2007 May 1;67(9):4210-8. Erratum in: Cancer Res. 2008 Jun 15;68(12):4958.

12.

The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and reduces murine early acute graft-versus-host disease mortality.

Sun K, Li M, Konopleva M, Konoplev S, Stephens LC, Kornblau SM, Frolova O, Wilkins DE, Ma W, Welniak LA, Andreeff M, Murphy WJ.

Biol Blood Marrow Transplant. 2007 May;13(5):521-9. Epub 2007 Feb 26.

13.

Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine.

Madoff DC, Gupta S, Pillsbury EP, Kan Z, Tinkey PT, Stephens LC, Ensor JE, Hicks ME, Wright KC.

J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):79-93.

PMID:
17296708
14.

mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.

Inoue S, Hartman A, Branch CD, Bucana CD, Bekele BN, Stephens LC, Chada S, Ramesh R.

Mol Ther. 2007 Feb;15(2):287-94.

15.

EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.

Hachem R, Bahna P, Hanna H, Stephens LC, Raad I.

Antimicrob Agents Chemother. 2006 May;50(5):1823-7.

17.

Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.

Wei C, Amos CI, Stephens LC, Campos I, Deng JM, Behringer RR, Rashid A, Frazier ML.

Cancer Res. 2005 Dec 15;65(24):11297-303.

18.

Phentermine and anaesthesia.

Stephens LC, Katz SG.

Anaesth Intensive Care. 2005 Aug;33(4):525-7.

19.

Long-term effects of neonatal exposure to hydroxylated polychlorinated biphenyls in the BALB/cCrgl mouse.

Martinez JM, Stephens LC, Jones LA.

Environ Health Perspect. 2005 Aug;113(8):1022-6.

20.

Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.

Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD, Xu K, Atkinson EN, Bekele BN, Stephens LC, Minna JD, Roth JA, Ramesh R.

Cancer Gene Ther. 2004 Nov;11(11):733-9.

PMID:
15486560
21.

Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.

Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC; Familial Adenomatous Polyposis Study Group.

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7.

22.

Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer.

Pisters LL, Pettaway CA, Troncoso P, McDonnell TJ, Stephens LC, Wood CG, Do KA, Brisbay SM, Wang X, Hossan EA, Evans RB, Soto C, Jacobson MG, Parker K, Merritt JA, Steiner MS, Logothetis CJ.

Clin Cancer Res. 2004 Apr 15;10(8):2587-93.

24.

Transvenous extrahepatic portacaval shunt: feasibility study in a Swine model.

Wallace MJ, Ahrar K, Stephens LC, Wright KC.

Radiology. 2003 Jul;228(1):119-25. Epub 2003 Apr 24.

PMID:
12714681
25.

Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.

Ito I, Began G, Mohiuddin I, Saeki T, Saito Y, Branch CD, Vaporciyan A, Stephens LC, Yen N, Roth JA, Ramesh R.

Mol Ther. 2003 Mar;7(3):409-18.

26.

Vesicourethral anastomosis with 2-octyl cyanoacrylate adhesive in an in vivo canine model.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.

Urology. 2002 Nov;60(5):935-8.

PMID:
12429341
27.

Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.

Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B.

Gene Ther. 2002 Oct;9(20):1379-86.

29.

Laser welded vesicourethral anastomosis in an in vivo canine model: a pilot study.

Grummet JP, Costello AJ, Swanson DA, Stephens LC, Cromeens DM.

J Urol. 2002 Jul;168(1):281-4.

PMID:
12050556
30.

Biological and genetic properties of the p53 null preneoplastic mammary epithelium.

Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL.

FASEB J. 2002 Jun;16(8):881-3. Epub 2002 Apr 10.

PMID:
11967232
31.

The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.

Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordoñez NG, Troncoso P, Navone NM.

Clin Cancer Res. 2002 Mar;8(3):775-81.

32.

Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP.

Ellerhorst JA, Stephens LC, Nguyen T, Xu XC.

Prostate. 2002 Jan 1;50(1):64-70.

PMID:
11757037
33.

Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.

Newman RA, Yang J, Raymond M, Finlay V, Cabral F, Vourloumis D, Stephens LC, Troncoso P, Wu X, Logothetis CJ, Nicolaou KC, Navone NM.

Cancer Chemother Pharmacol. 2001 Oct;48(4):319-26.

PMID:
11710633
34.

Radiation-induced morphologic changes in the rhesus monkey (Macaca mulatta) brain.

Price RE, Langford LA, Jackson EF, Stephens LC, Tinkey PT, Ang KK.

J Med Primatol. 2001 Apr;30(2):81-7.

PMID:
11491408
35.

In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.

Ho L, Aytac U, Stephens LC, Ohnuma K, Mills GB, McKee KS, Neumann C, LaPushin R, Cabanillas F, Abbruzzese JL, Morimoto C, Dang NH.

Clin Cancer Res. 2001 Jul;7(7):2031-40.

36.

Extent and kinetics of recovery of occult spinal cord injury.

Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1013-20.

PMID:
11429229
37.

Correlation of kidney weight and volume and selected skeletal parameters to sex in the adult rhesus monkey (Macaca mulatta).

Hill LR, Hess KR, Stephens LC, Price RE, Gray KN.

J Med Primatol. 2001 Feb;30(1):56-60.

PMID:
11396864
38.

Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.

Kornblau SM, Stiouf I, Snell V, Przepiorka D, Stephens LC, Champlin R, Marini FC 3rd.

Cancer Res. 2001 Apr 15;61(8):3355-60.

39.

Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.

Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.

Cancer Res. 2001 Apr 15;61(8):3330-8.

40.

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.

Ramesh R, Saeki T, Templeton NS, Ji L, Stephens LC, Ito I, Wilson DR, Wu Z, Branch CD, Minna JD, Roth JA.

Mol Ther. 2001 Mar;3(3):337-50.

41.

Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoprotein.

Bao JJ, Lee BP, Stephens LC, Sahin AA, Van NT, Johnston DA, Ou CN, Kuo MT.

Mol Carcinog. 2000 Oct;29(2):103-11.

PMID:
11074607
42.

Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin.

Strickland FM, Muller HK, Stephens LC, Bucana CD, Donawho CK, Sun Y, Pelley RP.

Photochem Photobiol. 2000 Sep;72(3):407-14.

PMID:
10989613
43.

Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines.

Kagawa S, Gu J, Swisher SG, Ji L, Roth JA, Lai D, Stephens LC, Fang B.

Cancer Res. 2000 Mar 1;60(5):1157-61.

44.

Interactions of apoptosis, proliferation and host age in the regression of the mouse mammary preneoplasia, TM3, carrying an unusual mutation in p53.

Bonnette SG, Kittrell FS, Stephens LC, Meyn RE, Medina D.

Carcinogenesis. 1999 Sep;20(9):1715-20.

PMID:
10469615
45.

Comparison of kidney weight and volume to selected anatomical parameters in the adult female rhesus monkey (Macaca mulatta).

Hill LR, Hess KR, Stephens LC, Tinkey PT, Price RE.

J Med Primatol. 1999 Apr;28(2):67-72.

PMID:
10431696
46.

Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.

Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC.

Clin Cancer Res. 1999 Jul;5(7):1793-804.

47.

Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model.

Levy DA, Cromeens DM, Evans R, Stephens LC, von Eschenbach AC, Pisters LL.

Urology. 1999 Jun;53(6):1245-51.

PMID:
10367863
48.

Skin graft survival after external beam irradiation.

Tadjalli HE, Evans GR, Gürlek A, Beller TC, Ang KK, Stephens LC.

Plast Reconstr Surg. 1999 Jun;103(7):1902-8.

PMID:
10359252
49.

Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.

Logsdon MD, Meyn RE Jr, Besa PC, Pugh WC, Stephens LC, Peters LJ, Milas L, Cox JD, Cabanillas F, Brisbay S, Andersen M, McDonnell TJ.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):19-29.

PMID:
10219790
50.

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

Haire WD, Ruby EI, Stephens LC, Reed E, Tarantolo SR, Pavletic ZS, Bierman PJ, Bishop M, Kessinger A, Vose J, Armitage JO.

Biol Blood Marrow Transplant. 1998;4(3):142-50.

Supplemental Content

Loading ...
Support Center